Human T cell lymphotropic virus types I and II in intravenous drug users in San Francisco: risk factors associated with seropositivity.
Human T cell lymphotropic virus types I and II in intravenous drug users in San Francisco: risk factors associated with seropositivity.
复制标题
旧金山静脉吸毒者中人类 T 细胞淋巴细胞病毒 I 型和 II 型:与血清阳性相关的危险因素。
DOI:
10.1093/infdis/164.1.36
复制
发表时间:
1991
期刊:
影响因子:
--
通讯作者:
Moss,A
中科院分区:
文献类型:
--
作者:
Feigal,E;Murphy,E;Vranizan,K;Bacchetti,P;Chaisson,R;Drummond,JE;Blattner,W;McGrath,M;Greenspan,J;Moss,A
Serologic assays for human T cell lymphotropic virus types I and II (HTLV I/II) infection were done in 676 intravenous drug users (IVDUs) in San Francisco between 1985 and 1987: 150 in 1985, 44 in 1986, and 482 in 1987. All sera were tested by Western blot, ELISA, and p24 RIA. A total of 111 participants were seropositive in a minimum of two assays. Duration of intravenous heroin use was strongly associated with the risk of HTLV I/II seropositivity: ⩾21 years odds ratio, 6.1 (95% confidence interval [Cl], 2.2–17.5), compared with ⩽10 years of heroin use. Additional independent risk factors included black or Hispanic race, female sex, and the use of drugs in a shooting gallery. Coinfection of HTLV I/II and human immunodeficiency virus was less frequent than expected by chance (P< .02). Longitudinal specimens were available in 154 participants. The age- and race-adjusted seroconversion rate was 3.4% (95% CI, 1.3–8.9) per person per year. Of the 349 homosexual men tested, none were HTLV I/II-seropositive